FDA Investigator Johann M Fitch

Johann M Fitch has inspections in 11 countries as of 07 Sep 2023. Johann M Fitch has collaborated with a combinined 3468 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
297
Last Inspection Date:
07 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Netherlands, Sweden, Argentina, Ukraine, Spain, Italy, Czechia, Bosnia and Herzegovina, Romania, Canada
Co-Investigator(s):
Adam C Hipko, Ademola O Daramola, Adrian Rodriguez, Akbar J Zaidi, Alcee M Tavarez, Andrea A Branche, Andrew J Lang, Anh M Lac, Anitha P Govada, Anthony L Smith, Anya D Lockett Evans, Aqualia L Nelson, Ashley N Williams, Axel M Ambert, Babatunde D Babalola, Betsy C Galliher, Bing Lin, Blondell W Johnson, Brackens Harris, Brandon K Barbee, Brenda G Stewart Munoz, Camerson E Moore, Camille D Brown, Carla A Norris, Carol A Declouette Wilburn, Charles B Steinmiller, Charles D Brown, Charles E Shaffer, Chmura, Christopher D Rush, Christopher J Hurst, Christopher L Jacobs, Cody J Alley, Corrine M Carter, Craig T Rybus, Cynthia A Harris, MD, RN, Daniel J Lahar, Danny D Horner, Darla J Christopher, David M Beltran, Demario L Walls, Denise Connelly, Deniza Karacic, Diana L Ayala, Diane Cvan Leeuwen, Diane L Raccasi, Don A Leeseberg, Dr. Jason R Caballero, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dwight D Ferguson, Ed Gonzalez Vazquez, Edmiston, Edward D Edmiston, Eias A Zahalka, Elisa M Fleming, Elizabeth A Girard, Elizabeth D Connell, Elkins, Emilio O Escobar, Ernest Serna, III, Florecia S Philogene, Francis A Guidry, Frans E Mercado, Frederic W French, III, Gery M Duparc, Gilbert Valdez, RS, Glasgow, Grant, Grant L Davis, Greg K Keshishyan, Gregory A Holt, Habacuc V Barrera, Hurst, Iris C Macinnes, James H Robinson, Janet B Abt, Janete F Guardia, Janice M Hickok, Jeffrey R Wooley, Jennifer D Young, Jennifer Owens Dowdy, Jocelyn C Turner, Jodi M Gatica, Joel D Martinez, Johnson, Jonaida Estevez Martinez, Jose E Melendez, DDC, Jose Martinez, Jr, Joseph E Duran, Joy L Ramsey, Juan D Lopez, Karen C Daugherty, Kari M Johansen, Karlton T Watson, Kathleen Chmura Shaffer, Kevin T Nguyen, Khunnathee Stoner, Kibily D Dembele, Kristi B Panzer, Kunapuli T Madhusudhan, Lance D Johnson, Lance Sindo, CIH, CQA, RS, Latorie S Jones, Laura E Pennington, Lauren R Brady, Lauren R Howell, Leighton K Ngai, Liliya V Bubiy, Lisa M Puttonen, Lisa M Yoder, Lisa R Jennings, Lloyd D Payne, Lorie S Hannappel, Lourdes R Genera, Lucas B Leake, Maira P Brading, Marc R Dickens, Margaret M Annes, Mariana F Baxter, Mark W Babbitt, Martinez, Mary R Reed, Massoud Motamed, Matthew R Maddox, Miaja Umaedi, Michelle A Krayer, Michelle C Webb, Monique Rac Lester, Navista C Bolton, Nicole J Clausen, Ninfa N Innocent, Patrice S Hall, Patricia M Jacobs, Patrick D Stone, MS, Patty P Kaewussdangkul, Paul E Frazier, Paula J Perry, Pauline N Logan, Percal Perez, Philip M Steele, PhD, Phillip J Sample, Pitman, Rebecca C O Bryan, Rebecca Rodriguez, Regina D Hunt, Rene R Ramirez, Rian L Pope, Richard T Riggie, Robert D Tollefsen, Robert M Tillman, Robert T Harris, Robert T Lorenz, Rodriguez, Ronan F King, Ronda R Loyd Jones, Ronnie Garza, Rose Ashley, Rose M Ashley, Roy Baby, Saijal P Naik, Sandy J Ziegler, Santos E Camara, Scott J Trsenjak, Scott T Ballard, Sean M Cheney, Selina M Mata, Sha'tina R Alridge, Shanna N Purdy, Sharon K Thoma, PharmD, Shawn E Larson, Shelby N Marler, Shelby N Turner, Sina Shojaee, Staci G Mcallister, State Agency, Stephen D Brown, Stephen L Beekman, Stuart W Russell, Suzanne N Vallez, Tamera H Hunt, Tara A Gray, Thomas J Arista, Thomas Martinez, Toby Vern H Hill, Torrance J Slayton, Tracy J Washington, Trang N Cox, Trang P Nguyen, Travis S Brown, Tricia S Martinez, Trina K Vick, Unnee Ranjan, Uttaniti Limchumroon (Tom), Ve Garcia, Vivian Garcia, Yaw O Osei, Youmin Wang, Young M Yoon, Youngjd, Zachary L Miller, Zerita White

Johann M Fitch's Documents

Publish Date Document Type Title
June, 2001 EIR Ceutical Laboratories, Inc. - EIR, 2001-06-07
July, 2003 EIR DPT Laboratories, Ltd. - EIR, 2003-07-21
May, 2004 FDA 483 Response DPT Laboratories, Ltd. - Form 483R, 2004-06-02
August, 2015 FDA 483 Response Charles W. Randall, M.D. - Form 483R, 2015-08-28
April, 2009 FDA 483 Kimberly Clark Corporation San Antonio Operations - Form 483, 2009-04-14
May, 2004 EIR DPT Laboratories, Ltd. - EIR, 2004-05-27
May, 2012 EIR LODC, Inc. - EIR, 2012-05-25
June, 2002 EIR Mission Pharmacal Company - EIR, 2002-06-25
August, 2003 EIR L'OREAL USA, INC. - EIR, 2003-08-08
September, 2016 FDA 483 Nicola Specchio - Form 483, 2016-09-30
October, 2018 EIR Worldwide Clinical Trials Early Phase Services, LLC - EIR, 2018-10-17
June, 2002 FDA 483 Mission Pharmacal Company - Form 483, 2002-06-25
August, 2009 FDA 483 DPT Laboratories, Ltd. - Form 483, 2009-08-28
July, 2019 FDA 483 William C. Biggs, M.D. - Form 483, 2019-07-12
February, 2009 FDA 483 Dr. David L. Fox, M.D. - Form 483, 2009-02-13
April, 2000 FDA 483 Mission Pharmacal Co - Form 483, 2000-04-12
May, 2006 FDA 483 Access Enet Solutions, Inc - Form 483, 2006-05-11
August, 2019 FDA 483 Richard M Evans, MD - Form 483, 2019-08-19
October, 2018 FDA 483 Worldwide Clinical Trials Early Phase Services, LLC - Form 483, 2018-10-17
December, 2004 FDA 483 Aloe Laboratories, Inc - Form 483, 2004-12-03
August, 2015 EIR Charles W. Randall, M.D. - EIR, 2015-08-18
April, 2000 EIR Mission Pharmacal Company - EIR, 2000-04-12
May, 2002 EIR Matthew Medlock, MD - EIR, 2002-05-24
April, 2003 EIR DPT Laboratories, Ltd. - EIR, 2003-04-01
September, 2017 FDA 483 University of Arkansas for Medical Sciences IRB - Form 483, 2017-09-29
October, 2019 FDA 483 David Fuentes, M.D. - Form 483, 2019-10-08
August, 2019 EIR Richard M Evans, MD - EIR, 2019-08-19
May, 2009 FDA 483 Response Goodier Cosmetics - Form 483R, 2009-05-28
May, 2004 FDA 483 DPT Laboratories, Ltd. - Form 483, 2004-05-27
May, 2000 EIR Medi Flex Hospital Products Inc - EIR, 2000-05-26
August, 2018 FDA 483 Ediberto Soto-Cora, MD - Form 483, 2018-08-17
August, 2003 FDA 483 Response L'OREAL USA, INC. - Form 483R, 2004-02-23
August, 2015 FDA 483 Charles W. Randall, M.D. - Form 483, 2015-08-18
March, 2000 EIR Paul Ratner, Dr/Clin Inv - EIR, 2000-03-02
August, 2017 FDA 483 Oeyama-Moto-Medical Group Foundation, LLC - Form 483, 2017-08-11
September, 2013 FDA 483 Kimberly Clark Corporation San Antonio Operations - Form 483, 2013-09-16
May, 2009 EIR Goodier Cosmetics - EIR, 2009-05-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more